109 related articles for article (PubMed ID: 17175303)
21. Successful therapy with rituximab of refractory acute humoral renal transplant rejection: a case report.
Celik A; Saglam F; Cavdar C; Sifil A; Atila K; Sarioglu S; Bora S; Gulay H; Camsari T
Transplant Proc; 2008; 40(1):302-4. PubMed ID: 18261611
[TBL] [Abstract][Full Text] [Related]
22. Detectable circulating antiendothelial cell antibodies in renal allograft recipients with C4d-positive acute rejection: a report of three cases.
Sun Q; Liu Z; Yin G; Chen H; Chen J; Li L
Transplantation; 2005 Jun; 79(12):1759-62. PubMed ID: 15973182
[TBL] [Abstract][Full Text] [Related]
23. Therapy with plasmapheresis and intravenous immunoglobulin for acute humoral rejection in kidney transplantation.
Ibernón M; Gil-Vernet S; Carrera M; Serón D; Moreso F; Bestard O; Cruzado JM; Grinyó JM
Transplant Proc; 2005 Nov; 37(9):3743-5. PubMed ID: 16386524
[TBL] [Abstract][Full Text] [Related]
24. C4d deposition is correlated with the level of antivimentin antibody in rat kidneys undergoing chronic allograft nephropathy.
Yang L; Lu YP; Luo GH; Song J; Tu ZD; Li YP
Transplant Proc; 2008 Oct; 40(8):2786-9. PubMed ID: 18929862
[TBL] [Abstract][Full Text] [Related]
25. C4d complement split product in diagnosis of immunological activity of chronic allograft nephropathy.
Mroz A; Lewandowski Z; Cieciura T; Matłosz B; Pazik J; Kwiatkowski A; Szmidt J; Durlik M
Transplant Proc; 2006; 38(1):97-100. PubMed ID: 16504674
[TBL] [Abstract][Full Text] [Related]
26. Tacrolimus plus low-dose mycophenolate mofetil in renal transplant recipients: better 2-year graft and patient survival than with a higher mycophenolate mofetil dose.
Kocak H; Yakupoglu U; Karatas GU; Yavuz A; Gurkan A; Erdogan O; Ersoy FF; Yakupoglu G; Demirbas A; Tuncer M
Transplant Proc; 2005 Sep; 37(7):3009-11. PubMed ID: 16213288
[TBL] [Abstract][Full Text] [Related]
27. Humoral immune response after kidney transplantation is enhanced by acute rejection and urological obstruction and is down-regulated by mycophenolate mofetil treatment.
Oliveira JG; Monteiro MS; Teixeira JF; Osório E; Norton SM; Alves H; Pestana M
Transpl Int; 2005 Nov; 18(11):1286-91. PubMed ID: 16221160
[TBL] [Abstract][Full Text] [Related]
28. [The early C4d urinary excretion and long-term kidney graft survival in patients treated with tacrolimus and mycophenolate mophetil].
Zwiech R
Pol Merkur Lekarski; 2014 Mar; 36(213):175-9. PubMed ID: 24779215
[TBL] [Abstract][Full Text] [Related]
29. Mycophenolate mofetil tolerability and dose changes in tacrolimus-treated renal allograft recipients.
Pascual J; Ocaña J; Marcén R; Fernández A; Galeano C; Alarcón MC; Burgos FJ; Villafruela JJ; Ortuño J
Transplant Proc; 2006 Oct; 38(8):2398-9. PubMed ID: 17097946
[TBL] [Abstract][Full Text] [Related]
30. Immunosuppression with generic tacrolimus and mycophenolate mofetil in renal transplant recipients: preliminary report in Chile.
Müller H; Solari S; Zuñiga C; Pedreros C; Troncoso J; Morente C; Ovalle R; Acosta P; Chavez T; Albornoz E
Transplant Proc; 2008 Apr; 40(3):705-7. PubMed ID: 18454992
[TBL] [Abstract][Full Text] [Related]
31. Probable C4d-negative accelerated acute antibody-mediated rejection due to non-HLA antibodies.
Niikura T; Yamamoto I; Nakada Y; Kamejima S; Katsumata H; Yamakawa T; Furuya M; Mafune A; Kobayashi A; Tanno Y; Miki J; Yamada H; Ohkido I; Tsuboi N; Yamamoto H; Yokoo T
Nephrology (Carlton); 2015 Jul; 20 Suppl 2():75-8. PubMed ID: 26031592
[TBL] [Abstract][Full Text] [Related]
32. Immunoadsorption in severe C4d-positive acute kidney allograft rejection: a randomized controlled trial.
Böhmig GA; Wahrmann M; Regele H; Exner M; Robl B; Derfler K; Soliman T; Bauer P; Müllner M; Druml W
Am J Transplant; 2007 Jan; 7(1):117-21. PubMed ID: 17109725
[TBL] [Abstract][Full Text] [Related]
33. Late acute antibody mediated rejection after nine years of renal transplantation.
Halim MA; Al-Otaibi T; Al-Waheeb S; Tawab KA; El Kholy O; Nair P; Said T; Narayanan Nampoory MR
Saudi J Kidney Dis Transpl; 2010 Nov; 21(6):1111-4. PubMed ID: 21060182
[TBL] [Abstract][Full Text] [Related]
34. Freedom from rejection and stable kidney function are excellent criteria for steroid withdrawal in tacrolimus-treated kidney transplant recipients.
Włodarczyk Z; Wałaszewski J; Perner F; Vitko S; Ostrowski M; Bachleda P; Kokot F; Klinger M; Szenohradsky P; Studenik P; Navratil P; Asztalos L; Rutkowski B; Nagy KK; Hickey D
Ann Transplant; 2002; 7(3):28-31. PubMed ID: 12465429
[TBL] [Abstract][Full Text] [Related]
35. Diagnosis of acute humoral rejection using immunofluorescence in renal allograft biopsies- one step towards better understanding!
Vanikar AV; Trivedi H; Patel RD; Kanodia KV; Trivedi VB; Shah PR; Gupta SB; Dabhi M; Gumber M; Goplani K
Indian J Pathol Microbiol; 2007 Jul; 50(3):502-6. PubMed ID: 17883118
[TBL] [Abstract][Full Text] [Related]
36. The presence of B-cell nodules does not necessarily portend a less favorable outcome to therapy in patients with acute cellular rejection of a renal allograft.
Doria C; di Francesco F; Ramirez CB; Frank A; Iaria M; Francos G; Marino IR; Farber JL
Transplant Proc; 2006 Dec; 38(10):3441-4. PubMed ID: 17175297
[TBL] [Abstract][Full Text] [Related]
37. C4D deposition and positive posttransplant crossmatch are not necessarily markers of antibody-mediated rejection in renal allograft recipients.
Banasik M; Boratyńska M; Nowakowska B; Haloń A; Kościelska-Kasprzak K; Drulis-Fajdasz D; Patrzałek D; Weyde W; Klinger M
Transplant Proc; 2007 Nov; 39(9):2718-20. PubMed ID: 18021967
[TBL] [Abstract][Full Text] [Related]
38. Tacrolimus in pancreas transplantation: a multicenter analysis. Tacrolimus Pancreas Transplant Study Group.
Gruessner RW
Clin Transplant; 1997 Aug; 11(4):299-312. PubMed ID: 9267719
[TBL] [Abstract][Full Text] [Related]
39. Late and early C4d-positive acute rejection: different clinico-histopathological subentities in renal transplantation.
Sun Q; Liu ZH; Ji S; Chen J; Tang Z; Zeng C; Zheng C; Li LS
Kidney Int; 2006 Jul; 70(2):377-83. PubMed ID: 16760909
[TBL] [Abstract][Full Text] [Related]
40. Rituximab therapy for acute humoral rejection after kidney transplantation.
Faguer S; Kamar N; Guilbeaud-Frugier C; Fort M; Modesto A; Mari A; Ribes D; Cointault O; Lavayssière L; Guitard J; Durand D; Rostaing L
Transplantation; 2007 May; 83(9):1277-80. PubMed ID: 17496547
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
